Status:

COMPLETED

Transitions of Care Stroke Disparity Study (TCSD-S)

Lead Sponsor:

University of Miami

Collaborating Sponsors:

National Institute on Minority Health and Health Disparities (NIMHD)

Conditions:

Stroke

Eligibility:

All Genders

18+ years

Brief Summary

The TCSD Study will identify disparities in transitions of stroke care and key factors associated with effective transitions of care through structured telephone interviews to evaluate medication adhe...

Detailed Description

The TCSD Study will identify disparities in transitions of stroke care and key factors associated with effective transitions of care through structured telephone interviews to evaluate medication adhe...

Eligibility Criteria

Inclusion

  • Ischemic stroke or intracerebral hemorrhage patients age \>/=18 years that are discharged directly to home, or discharged to rehab
  • Final diagnosis of ischemic stroke or intracerebral hemorrhage, included in the Get With
  • The Guidelines- Stroke (GWTG-S) database.
  • Patient or legally authorized representative provides consent
  • Available by phone and willing to receive two follow-up calls.

Exclusion

  • Cases with subarachnoid hemorrhage, transient ischemic attack (TIA), stroke not otherwise specified, no stroke related diagnosis, and admission for elective carotid intervention will be excluded.
  • Prisoners will be excluded. The purpose of the project is to study the hospital-to-home transition of stroke care.
  • Discharged to inpatient rehabilitation, nursing home, subacute rehabilitation facilities or assisted living facilities. These facilities support medication adherence, provide prescribed diets, often provide in-house medical follow-up, and therefore disparities in TOSC are less likely to be detected and not amenable to the proposed interventions.
  • Modified Rankin Scale of 0 after stroke. These individuals usually do not require any rehabilitation interventions and to avid the inclusion of predominately mild stroke patients.
  • Unable to obtain consent from patient or legally authorized representative.
  • Unavailable or unwilling to participate in the 30 and 90 day follow up telephone calls.

Key Trial Info

Start Date :

June 1 2018

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 11 2023

Estimated Enrollment :

1549 Patients enrolled

Trial Details

Trial ID

NCT03452813

Start Date

June 1 2018

End Date

December 11 2023

Last Update

April 16 2024

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Jackson Memorial Hospital

Miami, Florida, United States, 33136

2

University of Miami

Miami, Florida, United States, 33136